Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/22/2007US20070269494 Compositions and methods for enhancing active agent absorption
11/22/2007US20070269487 Drug Delivery Methods, Structures, and Compositions for Nasolacrimal System
11/22/2007US20070269486 Methods and Devices for Reducing Tissue Damage After Ischemic Injury
11/22/2007US20070269480 Medical devices having bioactive surfaces
11/22/2007US20070269463 Botulinum toxin formulation for oral administration
11/22/2007US20070269452 Methods and compositions for the diagnosis and treatment of cancer
11/22/2007US20070269450 Biologically active peptides
11/22/2007US20070269443 Therapeutic Regimens for Baff Antagonists
11/22/2007US20070269440 Stimulators of osteoblastogenesis and applications of the same
11/22/2007US20070269439 Use in diagnosis and treatment of cytokine disorders such as tumor metastasis, angiogenesis, cellular migration and ovulation, as well as neurogenesis
11/22/2007US20070269436 Method of Antibody Production
11/22/2007US20070269435 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/22/2007US20070269433 Cell cycle progressional proteins
11/22/2007US20070269431 Protein Involved In Cancer
11/22/2007US20070269426 Use of Soluble Gammadelta Cell Receptors for Regulating T Cell Function
11/22/2007US20070269423 kit comprises a nucleic acid, use for detection and treatment of human cancers by inhibiting the enzyme activities; biodrug as anticarcinogenic agents
11/22/2007US20070269421 Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp)
11/22/2007US20070269419 Use of Caspase-8 Inhibitors for Modulating Hematopoiesis
11/22/2007US20070269418 Hair Growth Inhibition
11/22/2007US20070269413 Transdiscal administration of high affinity anti-MMP inhibitors
11/22/2007US20070269408 GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT
11/22/2007US20070269407 Use of interleukin-19 to treat cervical cancer
11/22/2007US20070269406 Transcatheter tumor immunoembolization
11/22/2007US20070269405 Androgen Receptor Modulators
11/22/2007US20070269393 Topical anesthetic formulation
11/22/2007DE3790635B4 New sugar derivs. of biologically active peptide(s) - have prolonged duration of action, and are coupled by other than direct N-glycoside bond or direct amide bond
11/22/2007CA2652388A1 New use of therapeutically useful peptides
11/22/2007CA2652333A1 Pharmaceutical composition for treating or preventing hcv infection
11/22/2007CA2652274A1 Il-1.alpha. immunization induces autoantibodies protective against atherosclerosis
11/22/2007CA2652219A1 Macrocyclic compounds as antiviral agents
11/22/2007CA2652094A1 High-affinity antagonists of elr-cxc chemokines
11/22/2007CA2652015A1 Methods and compositions for treating and preventing peripheral nerve damage
11/22/2007CA2651990A1 Improved antimicrobial peptides
11/22/2007CA2651988A1 Pharmaceutical compositions for vein irritating drugs
11/22/2007CA2651805A1 Therapy
11/22/2007CA2651791A1 Methods for treating autoimmune diseases using a taci-ig fusion molecule
11/22/2007CA2651597A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
11/22/2007CA2651555A1 Methods and compositions related to tr4
11/22/2007CA2643680A1 Hcv/hiv inhibitors and their uses
11/22/2007CA2638868A1 Selective vpac2 receptor peptide agonists
11/22/2007CA2635011A1 Use of sialylated fusion polypeptides for inhibition of oculotropic viruses
11/22/2007CA2633439A1 Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists
11/21/2007EP1857555A1 Method for the production of a cell and/or tissue disease phase specific treatment
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007EP1857547A2 Further novel forms of interfering RNA molecules
11/21/2007EP1857546A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/21/2007EP1857489A1 Microparticle and pharmaceutical composition
11/21/2007EP1857466A2 Soluble interleukin-20 receptor
11/21/2007EP1857465A1 Method of producing protein by using hamster igf-1
11/21/2007EP1857464A2 Chlamydia antigens
11/21/2007EP1857463A1 Peptide having neuroprotective effects
11/21/2007EP1857146A1 Treatment of respiratory disorders
11/21/2007EP1857122A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857114A1 Particle and preparation containing the particle
11/21/2007EP1856533A1 Microglia facilitated amyloidogenesis assay
11/21/2007EP1856311A2 A method for identifying skin care composition-resistant skin-binding peptides
11/21/2007EP1856290A2 Identification of polynucleotides for predicting activity of compunds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
11/21/2007EP1856255A2 Method of expressing proteins with disulfide bridges
11/21/2007EP1856153A1 Ykl-40 monoclonal antibodies
11/21/2007EP1856148A1 Neuropeptides
11/21/2007EP1856147A1 A molecule and chimeric molecules thereof
11/21/2007EP1856145A2 Voltage dependent anion channel (vdac1) compositions and methods of use thereof for regulating apoptosis
11/21/2007EP1856143A2 Hivcon: anhiv immunogen and uses thereof
11/21/2007EP1856140A1 Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
11/21/2007EP1856091A1 Compounds for stabilizing factor vii polypeptide formulations
11/21/2007EP1856037A1 Amidino-compounds for stabilizing factor vii polypeptide formulations
11/21/2007EP1855716A2 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
11/21/2007EP1855715A2 Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
11/21/2007EP1855712A2 Fxiii variants with improved properties
11/21/2007EP1855711A2 USE OF BAFF TO TREAT Th2-MEDIATED CONDITIONS
11/21/2007EP1855710A1 Muscle regeneration
11/21/2007EP1855709A1 Use of myostatin (gdf-8) antagonists for improving wound healing and preventif fibrotic disease
11/21/2007EP1855708A1 Treating anemia by inhibition of vegf
11/21/2007EP1855707A1 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
11/21/2007EP1855706A2 Single branch heparin-binding growth factor analogs
11/21/2007EP1855705A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
11/21/2007EP1855703A1 Formulations and methods for delivery of growth factor analogs
11/21/2007EP1855661A1 Formulation for aviptadil
11/21/2007EP1855595A2 Pharmaceutical liposomal compositions
11/21/2007EP1699437B1 Method for preparing solid dosage form of desmopressin
11/21/2007EP1585538A4 Modified hemoglobin and methods of making same
11/21/2007EP1543324B1 Methods and compositions for grafting functional loops into a protein
11/21/2007EP1427824B1 Use of microbiology non-viral substances for treating acne
11/21/2007EP1385498B1 Fatty acids as neutrophil survival and activation factors.
11/21/2007EP1356071B1 Genetically engineered herpes virus for the treatment of cardiovascular disease
11/21/2007EP1319064B1 Gsk3 polypeptides
11/21/2007EP1315515B1 Method for treating schizophrenia and related psychoses, and the use of erythropoietin or erythropoietin derivatives for treating schizophrenic disorders and related psychoses
11/21/2007EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007EP1201245B1 Use of functional oral preparations
11/21/2007EP1200459B1 Compounds for treatment of infectious and immune system disorders and methods for their use
11/21/2007EP1188445B1 Drug composition containing lecithin-modified superoxide dismutase
11/21/2007EP1187919B1 Recombinant adenoviruses encoding the sodium/iodide symporter (nis)
11/21/2007EP1150996B1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/21/2007EP1088088B8 Diacylglycerol o-acyltransferase
11/21/2007EP1019087B1 Ganglioside immunostimulating complexes and uses thereof
11/21/2007EP0981374B1 Sustained-release delayed gels
11/21/2007EP0904378B1 Hepatitis b monoclonal antibodies
1 ... 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 ... 3163